Ameriprise’s Legence Corp LGN Stock Holding History

Ameriprise’s Portfolio LGN Stock Details LGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$50.5M	Buy	592,378 +366,426	+162%	+$29.9M	0.01%	948
2026 Q1	$12.8M	Buy	+225,952	New	+$11.4M	﹤0.01%	1742

Other funds holding LGN

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FACM

Forest Avenue Capital Management Miami, Florida $2.38B AUM 88.67% 1-Year Est. Return

Ameriprise's LGN Position: Q2 2026 in Review

Ameriprise increased its Legence Corp (LGN) stake by 162% in Q2 2026, buying an estimated $29.9M and bringing the position to 592,378 shares worth $50.5M. The position accounts for 0.01% of the portfolio, ranked #948.

Ameriprise first reported a position in LGN in Q1 2026 and has held it in 2 quarters since. 267 funds tracked by Wall St. Rank hold LGN as of Q2 2026.

Ameriprise held 592,378 shares of Legence Corp worth $50.5M as of Q2 2026.
Ameriprise bought 366,426 Legence Corp shares in Q2 2026, an estimated $29.9M.
Legence Corp made up 0.01% of Ameriprise's portfolio in Q2 2026, its #948 holding.
Ameriprise first reported a position in Legence Corp in Q1 2026 and has held it in 2 quarters since.
267 funds tracked by Wall St. Rank held Legence Corp as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.